ABSTRACT
Antecedentes: la ansiedad es una enfermedad que genera inquietud y preocupación excesiva ante algo amenazante, esta condición origina un trastorno a quien lo padece. Un postulado teórico es la teoría de la ansiedad de Beck (Beck et al., 1999). En Perú hay diversas cifras de grupos de poblaciones que padecen esta enfermedad, pero no hay estudios de cuestionarios adaptados que midan la ansiedad siendo poco fiables en un contexto nacional. Frente a ello, este inventario es una buena opción que se ajusta a necesidades para medir la sintomatología de esta afectación. Objetivo: adaptar el Inventario de ansiedad de Beck en jóvenes peruanos. Método: tipo psicométrico y diseño instrumental. Resultados: en la validez basada en la estructura interna del instrumento, en el AFC (χ2/gl = 3.82; CFI = .98; SRMR = .03; RMSEA = .07); en cuanto a la validez basada en la relación con otras variables (r = .84; p < .001; r2 = .70), y en la confiabilidad de la escala (α = .95) lo que significa que la prueba presenta buen nivel de consistencia interna. Conclusiones: la prueba presenta evidencias aceptables de validez y confiabilidad para medir la variable. Palabras clave: ansiedad; adaptación; validez; confiabilidad; jóvenes; peruanos.
Background: Anxiety is a disease that generates restlessness and excessive worry about something threatening, this condition causes disorder for those who suffer from it. A theoretical postulate is Beck's theory of anxiety (Beck et al., 1999). In Peru there are various figures of population groups that suffer from this disease, but there are no studies of adapted questionnaires that measure anxiety, which are unreliable in a national context. Faced with this, this inventory is a good option that meets the needs to measure the symptomatology of this condition. Objective: Adapt the Beck anxiety inventory in young Peruvians. Method: Psychometric type and instrumental design. Results: In the validity based on the internal structure of the instrument, in the CFA (χ2/df = 3.82; CFI = .98; SRMR = .03; RMSEA = .07); in terms of validity based on the relationship with other variables (r = .84; p < .001; r2 = .70), and on the reliability of the scale (α = .95), which means that the test presents good level of internal consistency. Conclusions: The test presents acceptable evidence of validity and reliability to measure the variable. Keywords: anxiety; adaptation; validity; reliability; youth; Peruvians.
ABSTRACT
El diagnóstico de la infección por Clostridioides dfficile (ICD) ha aumentado en el embarazo y periparto. Cambios fisiológicos e inmunológicos normales durante el embarazo pueden incrementar el riesgo de ICD. Mujeres embarazadas con ICD tienen una mayor frecuencia de fracaso al tratamiento y una significativa morbilidad y mortalidad. El trasplante de microbiota fecal (TMF) se ha convertido en el tratamiento estándar de la ICD recurrente y refractaria. Sin embargo, existen escasos datos sobre sus resultados en mujeres embarazadas. Presentamos el caso de una mujer embarazada que se sometió con éxito a un TMF para el tratamiento de una ICD recurrente.
The diagnosis of Clostridioides dfficile infection (CDI) in pregnant and peripartum women has increased. In this scenario, there are higher rates of treatment failure and a significant maternal morbidity and mortality. Fecal microbiota transplant (FMT) has become the gold standard for the treatment of recurrent and refractory CDI however, there are few data on its results in pregnant patients. This case showed that FMT could be a therapeutic strategy in pregnant women with recurrent CDI.
Subject(s)
Humans , Female , Adult , Pregnancy Complications, Infectious/therapy , Colonoscopy/methods , Clostridium Infections/therapy , Fecal Microbiota Transplantation/methods , Recurrence , Vancomycin/therapeutic use , Clostridioides difficile , Anti-Bacterial Agents/therapeutic useABSTRACT
Clostridioides difficile infection (CDI) is a major public health problem and responsible for significant morbidity and mortality. Eighty percent of CDIs occur in adults older than 65 years of age due to a decreased gastrointestinal microbial diversity, immunosenescence and frailty. Thus, the most reported risk factor for recurrent CDI is older age since nearly 60% of cases occur in individuals aged ≥ 65 years. Fecal microbiota transplantation (FMT) is a highly cost-effective alternative to antibiotic treatment for patients with recurrent CDI. We report a 75-year-old male with recurrent CDI, who received a FMT after several unsuccessful antimicrobial treatments. He had a satisfactory evolution after the procedure and remained without diarrhea during the ensuing five months.